To further explore this, we quantified the levels of cleaved caspase-3 in osteosarcoma cells treated with Paucatalinone A. Our results reveal a significant increase in cleaved caspase-3 levels in cells exposed to Paucatalinone A (Figure 6C), indicating activation of apoptotic pathways. The gene discussed is CASP3; the disease is osteosarcoma.